Skip to content
Search

Latest Stories

Many rural areas could become 'pharmacy deserts' if the current closure rates continue

Many rural areas could become 'pharmacy deserts' if the current closure rates continue

NPA warns that England faces a material threat to the availability of vital medicines if “a decade of underfunding and pharmacy closures” is not addressed

Rural areas have been hit the hardest by a wave of pharmacy closures over the past two years, according to a new analysis by the National Pharmacy Association (NPA).


The analysis published today revealed that nearly nine in ten council areas across England have suffered the loss of vital pharmacies and warned that many rural areas risk becoming "pharmacy deserts" if the current closure rates continue.

Additionally, the NPA, which represents independent community pharmacies, warned that England faces a significant risk to the availability of essential medicines if “a decade of underfunding and closures” is not addressed.

It is calling on the government to reverse the 40 per cent real-terms cuts to community pharmacy budgets over the past decade, which have led to the closure of over 1,500 pharmacies and forced many others to reduce their opening hours.

NPA Chief Executive, Paul Rees said: “These shocking statistics show how a growing number of areas are at risk of becoming pharmacy deserts, with people in rural towns and villages having to travel longer and longer distances to get hold of the medication they need.

“Many pharmacies are on the brink because of a decade of real term cuts, creating a material threat to the security of medicine supply in some areas if closures continue.”

The analysis examined the number of pharmacies in each council area compared to their population and revealed several concerning trends.

In the past two years, 87 per cent of council areas have witnessed at least one pharmacy closure.

Rural areas are disproportionately affected, with 17 out of the bottom 20 areas for pharmacies per 100,000 people are councils covering rural areas.

Among the 20 council areas with the lowest pharmacy provision, 95 per cent have experienced at least one pharmacy closure in the last two years.

Council areas with higher levels of deprivation have seen the most closures during the period, further exacerbating health inequalities.

Notably, 80 per cent of the top 20 areas for closures have higher than average levels of deprivation, including Plymouth, North East Lincolnshire, Liverpool and Torbay.

The analysis showed that West Berkshire has the lowest number of pharmacies per 100,000 people in the country, shortly followed by Central Bedfordshire, Wiltshire and Oxfordshire, with all areas having seen pharmacies close in the last two years.

Ironically, West Berkshire, the area with the lowest pharmacy provision in the country, has over four times fewer pharmacies per 100,000 people compared to Westminster, the area with the highest provision.

Plymouth has seen the highest number of pharmacy closures per 100,000 of its population, with York, Liverpool, Darlington and Wakefield all close behind.

The analysis also found that over 90 per cent of an average community pharmacy’s income is dependent on funding from the NHS, including for the dispensing of medication and the Pharmacy First programme.

The NPA expressed concern that, without urgent action from the government, many rural areas could be left with little or no pharmacy provision at all, potentially forcing vulnerable or elderly residents to travel long distances to access essential medications or treatment.

Rees highlighted that the higher rate of pharmacy closures in deprived council areas has undermined government post-pandemic efforts to tackle health inequalities.

“The government needs to act now to stabilise the pharmacy network and lay out a routemap for a properly funded future or they will put the supply of medicine to some areas at risk,” he said.

Rees urged Ministers to provide pharmacies with a new deal to fix the “current broken contract”, which could halt the closures and allow pharmacies to deliver first-class accessible healthcare on people’s doorsteps.

Commenting on the NPA analysis, Janet Morrison, Chief Executive of Community Pharmacy England (CPE), stated that the financial and operational pressures are becoming “unbearable” for community pharmacies.

She noted that community pharmacies are “the front door to the NHS, providing critical health services and relieving pressure on GPs and other primary care services.”

However, pharmacy funding has been cut by 30 per cent in real terms since 2015, forcing many to close, especially in deprived communities and many rural areas.

There have been over 1,000 pharmacy closures since 2016, with local communities across England losing vital services, according to Morrison.

“This is a number that is simply too many. Pharmacy owners don’t want to close their businesses, but without sustainable funding, many have no choice,” she said.

Morrison stated that this analysis serves as yet another clear warning to the government and the NHS that things cannot continue like this.

She emphasised the need to prevent further closures by investing in community pharmacies and offering a sustainable funding model.

“Without this, patients, especially the most vulnerable, will find it increasingly difficult to access essential medications and healthcare services,” Morrison added.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less